Workflow
The Joint (JYNT)
icon
Search documents
The Joint Corp. (JYNT) Q4 Earnings and Revenues Top Estimates
Zacks Investment Research· 2024-03-08 00:55
The Joint Corp. (JYNT) came out with quarterly earnings of $0.07 per share, beating the Zacks Consensus Estimate of $0.03 per share. This compares to earnings of $0.04 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 133.33%. A quarter ago, it was expected that this company would post earnings of $0.04 per share when it actually produced a loss of $0.05, delivering a surprise of -225%.Over the last four quarters, the company ha ...
The Joint Corp. Reports Fourth Quarter and Year-end 2023 Financial Results
Newsfilter· 2024-03-07 21:20
- Grew 2023 Revenue 16%, System-wide Sales 12%, and System-wide Comp Sales 4% vs. 2022 - - Increased Clinic Count to 935 at Year-end 2023, Initiating Refranchising Program - SCOTTSDALE, Ariz., March 07, 2024 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ:JYNT), a national operator, manager, and franchisor of chiropractic clinics, reported its financial results for the quarter and year ended December 31, 2023. Financial Highlights: Q4 2023 Compared to Q4 2022 Grew revenue 11% to $30.6 million.Recorded net los ...
The Joint (JYNT) - 2023 Q4 - Annual Report
2024-03-07 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______ to ________ Commission File Number: 001-36724 The Joint Corp. (Exact name of registrant as specified in its charter) Delaware 90-0544160 (State or Other Jurisdiction ...
The Joint (JYNT) - 2023 Q4 - Annual Results
2024-03-06 16:00
EXHIBIT 99.1 The Joint Corp. Reports Fourth Quarter and Year-end 2023 Financial Results - Grew 2023 Revenue 16%, System-wide Sales 12%, and System-wide Comp Sales 4% vs. 2022 - - Increased Clinic Count to 935 at Year-end 2023, Initiating Refranchising Program - _____________________________________ Grew revenue 11% to $30.6 million. Recorded net loss on disposition or impairment of $1.5 million, compared to $50,000. Recorded operating loss of $147,000, compared to operating income of $1.5 million. Recorded ...
The Joint (JYNT) to Report Q4 Earnings: Here Are the Key Drivers
Zacks Investment Research· 2024-03-05 18:06
The Joint Corp. (JYNT) is set to report its fourth-quarter 2023 results on Mar 7, after the closing bell. It is expected to have witnessed increased clinic count and patient visits in the December quarter.Earnings Surprise HistoryThe Joint’s earnings beat the consensus estimate once in the prior four quarters and missed thrice, with the average surprise being 112.2%. This is depicted in the graph below:In the last reported quarter, the franchisor of chiropractic clinics reported adjusted operating loss per ...
The Joint Corp. to Participate in the 36th Annual Roth Conference
Newsfilter· 2024-03-04 12:05
SCOTTSDALE, Ariz., March 04, 2024 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ:JYNT), the nation's largest provider of chiropractic care through The Joint Chiropractic® network, announced that management is scheduled to attend the 36th Annual Roth Conference on March 17th – 19th. The conference is being held at The Ritz Carlton in Dana Point, CA. President and Chief Executive Officer Peter Holt and Chief Financial Officer Jake Singleton will participate in a fireside chat with analyst George Kelly on Tuesday ...
The Joint Corp. to Host Conference Call on Thursday, March 7th to Discuss Fourth Quarter and Year-end 2023 Results
Globenewswire· 2024-02-22 12:05
SCOTTSDALE, Ariz., Feb. 22, 2024 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), the nation's largest provider of chiropractic care through The Joint Chiropractic® network, announced it will report its fourth quarter and year-end 2023 financial results on Thursday, March 7, 2024, after the market close. President and CEO Peter D. Holt and CFO Jake Singleton will hold a conference call at 5:00 p.m. EDT that day to discuss the results. Shareholders and interested participants may listen to a live broadcas ...
The Joint Corp. to Host Conference Call on Thursday, March 7th to Discuss Fourth Quarter and Year-end 2023 Results
Newsfilter· 2024-02-22 12:05
SCOTTSDALE, Ariz., Feb. 22, 2024 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), the nation's largest provider of chiropractic care through The Joint Chiropractic® network, announced it will report its fourth quarter and year-end 2023 financial results on Thursday, March 7, 2024, after the market close. President and CEO Peter D. Holt and CFO Jake Singleton will hold a conference call at 5:00 p.m. EDT that day to discuss the results. Shareholders and interested participants may listen to a live broadcas ...
The Joint Chiropractic Named No. 1 in Chiropractic Services, Ranked Among Top Franchises in Entrepreneur Magazine's Franchise 500
Prnewswire· 2024-01-24 13:45
SCOTTSDALE, Ariz., Jan. 24, 2024 /PRNewswire/ -- The Joint Corp. (NASDAQ: JYNT), the nation's largest provider of chiropractic care through The Joint Chiropractic® network, has been named the top franchise in chiropractic services by Entrepreneur Magazine's Franchise 500, the world's first and most comprehensive franchise ranking. The Joint ranked No. 83 on the 2024 list, and has also been named a 2023 top franchise for veterans. "It is a great honor to start 2024 by being named the top chiropractic franch ...
The Joint Corp. Reports 2023 Operating Metrics
Newsfilter· 2024-01-11 12:05
- Grows Annual System-Wide Sales 12%, Compared to 2022 -- Increases Comp Sales of 4%, Compared to 2022 - - Opens 114 New Clinics, Expanding Year-end Total Clinic Count to 935 - SCOTTSDALE, Ariz., Jan. 11, 2024 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ:JYNT), a national operator, manager, and franchisor of chiropractic clinics, provided operating metrics for the year ended 2023. 2023 Full Year Operating Highlights Performed 13.6 million patient visits, compared to 12.2 million in 2022.Treated 932,000 new ...